How to interpret letrozole statistics

The mistakes that turn useful evidence into misleading promises

Fertility statistics are emotionally powerful. A high number can create false certainty, while a low number can remove hope too quickly. The number itself is only useful when you understand who was studied, what outcome was measured and how closely the study resembles your situation.

Mistake 1: treating ovulation as pregnancy

Ovulation rates describe whether the ovaries responded. Pregnancy and live birth require several additional steps. Articles that lead with a high ovulation percentage may create an unrealistic impression of the chance of taking home a baby.

Mistake 2: reading cumulative success as a per-cycle rate

The landmark 27.5% letrozole result was measured across up to five PCOS treatment cycles. It does not mean that 27.5% of participants had a live birth in every cycle. Cumulative rates naturally rise as more attempts are included.

Mistake 3: applying PCOS evidence to every diagnosis

Letrozole is best supported for anovulatory PCOS without another major infertility factor. A person with unexplained infertility, endometriosis, blocked tubes or significant sperm problems has a different prognosis even when the medicine and age are the same.

Mistake 4: ignoring the denominator

A rate may be calculated per cycle started, per person randomised, per person who ovulated, per insemination or per embryo transfer. Excluding people who cancelled treatment or did not respond can make a result appear better than the experience of everyone who began treatment.

Mistake 5: comparing different treatment settings

Timed intercourse, IUI and IVF are different pathways. Studies may use different sperm preparation, monitoring, trigger injections, cancellation rules and patient selection. Their percentages should not be compared as though the treatments were identical.

Mistake 6: treating age bands as individual predictions

Age groups are useful for population counselling. They can hide meaningful differences in ovarian reserve, sperm, tubal health, duration of infertility, previous pregnancies and treatment response. Someone at the younger end of a band may also have a different outlook from someone at the older end.

How to recognise a trustworthy fertility claim

A practical example

A more accurate version is: “In a trial of women aged 18-40 with anovulatory PCOS, 27.5% of those assigned to letrozole had a live birth over up to five cycles. The result was cumulative and should not be treated as a universal per-cycle or age-specific probability.”

Questions to ask when you see a percentage online

• What exactly happened to count as success?

• Was the result measured per cycle or over several cycles?

• Were all people who started treatment included?

• Did participants have PCOS, unexplained infertility or another diagnosis?

• Was treatment timed intercourse, IUI or IVF?

• How old were participants, and how broad were the age groups?

• Is the claim linked to the original source?

• What important factors are missing from the headline?

The bottom line

Good fertility information should improve your questions, not replace clinical assessment. Read every percentage as a description of a specific group and outcome. Then ask whether that group, outcome and treatment pathway genuinely resemble yours.

References

1. Legro, R.S. et al. (2014) Letrozole versus clomiphene for infertility in the polycystic ovary syndrome. New England Journal of Medicine, 371, 119-129.

2. Franik, S. et al. (2022) Aromatase inhibitors (letrozole) for ovulation induction in infertile women with polycystic ovary syndrome. Cochrane Database of Systematic Reviews, Issue 9.

3. Diamond, M.P. et al. (2015) Letrozole, gonadotropin, or clomiphene for unexplained infertility. New England Journal of Medicine, 373, 1230-1240.

4. NICE (2026) Fertility problems: assessment and treatment. NICE guideline NG257.